Recombinant Bacillus subtilis Putative hydrolase ydeN (ydeN)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. Note: We will preferentially ship the available format. If you have specific format requirements, please specify them when ordering.
Lead Time
Delivery times vary based on purchasing method and location. Consult your local distributor for specific delivery times. Note: Products are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ydeN; BSU05260; Putative hydrolase YdeN; EC 3.-.-.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-190
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus subtilis (strain 168)
Target Names
ydeN
Target Protein Sequence
MTKQVYIIHG YRASSTNHWF PWLKKRLLAD GVQADILNMP NPLQPRLEDW LDTLSLYQHT LHENTYLVAH SLGCPAILRF LEHLQLRKQL GGIILVSGFA KSLPTLQMLD EFTQGSFDHQ KIIESAKHRA VIASKDDQIV PFSFSKDLAQ QIDAALYEVQ HGGHFLEDEG FTSLPIVYDV LTSYFSKETR
Uniprot No.

Q&A

What is the structural classification of B. subtilis YdeN?

YdeN from Bacillus subtilis displays a canonical α/β hydrolase fold, albeit with some structural differences from the typical architecture. The protein consists of six central parallel β-strands with the topology 213456 and eight α-helices. Unlike most α/β hydrolases, YdeN lacks the typically observed first two antiparallel strands. The protein contains a strand-turn-helix motif following β3 that is consistent with the nucleophilic elbow motif characteristic of α/β hydrolases .

What are the key structural features of YdeN's active site?

The active site of YdeN contains a catalytic triad typically found in hydrolytic enzymes. There are several hydrophobic amino acids in close proximity to the triad, including Val140, Ile139, Leu109, Leu106, Leu103, Phe99, and His70. Together, these residues form a well-defined specificity pocket. The nucleophilic elbow region contains a sequence similar to that found in lipases from filamentous fungi, where the fingerprint sequence around the nucleophilic serine deviates slightly from the canonical Gly-X₁-Ser-X₂-Gly pattern by having an alanine replace the first glycine .

How does YdeN compare to other members of the α/β hydrolase family?

YdeN belongs to a small family of homologous microbial proteins, including a conserved hypothetical protein from Mycoplasma penetrans (43% identity), a predicted esterase from Actinobacillus pleuropneumoniae serovar (40% identity), and a hypothetical protein from Photorhabdus luminescens (36% identity). Sequence alignment shows that all residues lining the specificity pocket are closely conserved in this family, with only minor deviations. This conservation suggests that all proteins in this family may hydrolyze the same or closely related substrates .

What crystallization approach was successful for the YdeN protein?

The YdeN protein was successfully crystallized using a rational surface engineering approach. Traditional high-throughput crystallization methods had previously failed with the wild-type protein. Researchers employed site-directed mutagenesis to create patches of low conformational entropy on the protein surface to facilitate crystal contact formation. Of three prepared double mutants (E124A/K127A, E167A/E169A, and K88A/Q89A), the K88A/Q89A variant yielded high-quality crystals that diffracted to 1.8 Å resolution .

What technical challenges are typically encountered when crystallizing proteins like YdeN?

Crystallization of proteins like YdeN often faces challenges due to high surface entropy, which impedes the formation of stable crystal contacts. Surface regions with high conformational entropy, particularly those containing amino acids with long flexible side chains like lysine, glutamate, and glutamine, can interfere with proper crystal packing. For YdeN specifically, the wild-type protein failed to crystallize in high-throughput screening, requiring a targeted approach of surface modification to overcome this hurdle .

How was the structure of YdeN solved and refined?

The structure of YdeN was solved using Single-wavelength Anomalous Diffraction (SAD) at 1.8 Å resolution. The molecular model, including hydrogen atoms and anisotropic displacement parameters, was refined to a conventional R factor of 12.4%. This high-resolution structure allowed for detailed analysis of the active site architecture and inference of potential substrate specificity based on the arrangement of residues in the binding pocket .

What is the predicted enzymatic function of YdeN?

Based on structural analysis, YdeN is predicted to function as a hydrolase active on water-soluble esters. While many α/β hydrolases are lipases, YdeN lacks a lid that would allow interfacial activation, suggesting it is not a true lipase. Comparison with carboxylesterase from Pseudomonas fluorescens revealed that several residues in YdeN (Ile139, Leu109, Leu106, His70) correspond to residues that build the specificity pocket found in the carboxylesterase. These structural similarities, combined with sequence conservation among YdeN homologs, strongly suggest that YdeN functions as a carboxylesterase active on water-soluble esters where the substrate, possibly the acyl group, has a hydrophobic nature .

How can researchers experimentally determine the specific substrates of YdeN?

To determine the specific substrates of YdeN, researchers should consider implementing the following methodological approach:

  • Enzymatic assays with candidate substrates: Test activity against a panel of model ester substrates with varying acyl chain lengths and chemical properties (e.g., p-nitrophenyl esters, thioesters, and natural esters).

  • Structure-guided substrate docking: Use the high-resolution crystal structure to perform in silico docking studies with potential substrates to identify those that fit optimally in the specificity pocket.

  • Comparative analysis: Examine the activities of homologous proteins with known functions, particularly the closely related proteins from Mycoplasma penetrans, Actinobacillus pleuropneumoniae, and Photorhabdus luminescens.

  • Site-directed mutagenesis: Mutate key residues in the specificity pocket to assess their impact on substrate binding and catalysis.

  • Metabolomic approaches: Analyze the metabolite profiles of wild-type versus YdeN knockout strains to identify potential in vivo substrates.

What differentiates YdeN from lipases despite its structural similarity?

Despite sharing the α/β hydrolase fold with lipases, YdeN lacks the characteristic lid domain that covers the active site in lipases and enables interfacial activation. Lipases typically function at the interface of aqueous and lipid phases, requiring this conformational change for activity. The absence of this feature in YdeN suggests it acts on soluble substrates rather than at interfaces. Additionally, the arrangement of hydrophobic residues in YdeN's specificity pocket appears optimized for binding water-soluble esters with hydrophobic moieties rather than the extended hydrophobic substrates typical of lipases .

What expression systems are suitable for recombinant production of YdeN?

For recombinant production of YdeN, researchers have several expression system options:

  • E. coli expression system: Traditional prokaryotic expression in E. coli strains like BL21(DE3) or Rosetta(DE3) can be used for intracellular expression of YdeN with appropriate tags for purification.

  • B. subtilis expression system: As demonstrated with other proteins, B. subtilis itself can serve as an excellent host for homologous expression of YdeN. This system offers advantages including:

    • Minimal endotoxin levels compared to Gram-negative bacteria

    • Natural secretion capability for extracellular production

    • Ability to form spores for long-term storage of the expression strain

  • Alternative systems: For challenging expression scenarios, yeast or Brevibacillus expression systems might also be considered, particularly if post-translational modifications are required .

What purification challenges might researchers encounter with recombinant YdeN?

Purification of recombinant YdeN may present several challenges:

  • Inclusion body formation: If expressed in E. coli, YdeN may form inclusion bodies requiring denaturation and refolding procedures. This typically involves solubilization in denaturing agents like guanidine hydrochloride followed by optimized refolding conditions .

  • Protein solubility issues: As observed with other recombinant proteins, optimizing buffer conditions (pH, salt concentration, additives) may be necessary to maintain YdeN solubility during purification.

  • Maintaining enzymatic activity: Ensuring that the purification process preserves the catalytic activity of YdeN is critical, particularly if harsh denaturation/refolding approaches are employed.

  • Tag interference: If using tagged constructs for purification, researchers should verify that the tags do not interfere with folding, activity, or crystallization properties.

What methodology is recommended for purifying YdeN from inclusion bodies?

Based on methodologies successfully applied to similar proteins, the following approach is recommended for purifying YdeN from inclusion bodies:

  • Isolation of inclusion bodies: Resuspend cell pellets in appropriate buffer, sonicate on ice (using 15×5s pulses with 15s recovery between pulses), and collect inclusion bodies via centrifugation .

  • Denaturation: Solubilize inclusion bodies in guanidine denaturation buffer to completely unfold the protein .

  • Optimization of refolding conditions: Determine optimal refolding conditions using a refolding matrix that tests various buffers, additives, and pH conditions. For proteins similar to YdeN, buffer systems containing HEPES (50 mM), NDSB-201 (0.5 M), divalent cations (CaCl₂, MnCl₂, MgCl₂ at 0.25 mM each), reducing agents (TCEP 1 mM), and salts (NaCl 24 mM, KCl 1 mM) at pH 7.5 have proven effective .

  • Purification of refolded protein: After refolding, purify the protein using appropriate chromatography techniques based on the tags or properties of YdeN.

  • Storage: For long-term storage, dilute purified YdeN in glycerol (50% final concentration) and store at -80°C .

How can surface engineering approaches used with YdeN be applied to other challenging proteins?

The successful crystallization of YdeN through surface engineering provides a valuable methodological framework for other challenging proteins:

  • Target selection for mutagenesis: Identify surface residues with high conformational entropy (particularly Lys, Glu, Gln) located on putative loops that could interfere with crystal contact formation.

  • Rational design of mutations: Create double or triple mutations converting these high-entropy residues to alanines to create low-entropy patches conducive to crystal formation.

  • Screening strategy: Prepare multiple surface variants simultaneously and screen them in parallel crystallization trials to increase chances of success.

  • Validation approach: Confirm that surface mutations do not affect the core structure or function of the protein through activity assays or other functional tests.

This methodology has broader implications beyond YdeN, as it was shown to be effective for proteins that failed in high-throughput crystallization pipelines, potentially addressing one of the major bottlenecks in structural genomics efforts .

How might YdeN's hydrolytic activity be exploited in biotechnological applications?

YdeN's predicted carboxylesterase activity could be valuable in several biotechnological contexts:

  • Biocatalysis: YdeN could potentially catalyze stereoselective hydrolysis reactions for the production of chiral building blocks in pharmaceutical synthesis.

  • Biosensors: If YdeN shows high specificity for certain substrates, it could be incorporated into biosensor platforms for detection of these compounds.

  • Remediation applications: Depending on substrate specificity, YdeN might be useful for breaking down specific environmental contaminants.

  • Modification of natural products: YdeN could be employed in enzymatic modification of natural compounds to generate derivatives with altered properties.

For these applications, researchers would need to thoroughly characterize YdeN's substrate specificity, stability under various conditions, and compatibility with organic solvents or other reaction components typically used in biotechnological processes.

What approaches can be used to engineer YdeN for altered substrate specificity?

To engineer YdeN for altered substrate specificity, researchers can employ several strategies:

  • Structure-guided mutagenesis: Using the high-resolution crystal structure, identify residues in the specificity pocket (Val140, Ile139, Leu109, Leu106, Leu103, Phe99, His70) and introduce targeted mutations to accommodate different substrates.

  • Directed evolution: Develop a high-throughput screening or selection system for YdeN activity and apply random mutagenesis or gene shuffling techniques to generate variants with altered specificity.

  • Domain swapping: Exchange the specificity-determining regions of YdeN with corresponding regions from related enzymes with different substrate preferences.

  • Computational design: Utilize computational protein design algorithms to predict mutations that would optimize binding of novel substrates.

  • Active site expansion/contraction: Modify the size and shape of the active site by introducing mutations that expand or contract the binding pocket to accommodate larger or smaller substrates, respectively.

The success of these approaches would depend on developing robust assays to measure YdeN activity against various substrates and establishing structure-function relationships as the enzyme is modified.

What is the native biological role of YdeN in B. subtilis?

While the exact native biological role of YdeN in B. subtilis remains to be fully elucidated, structural and sequence analyses provide insights into its potential functions. As a putative carboxylesterase active on water-soluble esters with hydrophobic characteristics, YdeN likely participates in metabolic processes involving the hydrolysis of specific cellular esters or thioesters. The conservation of YdeN across related bacterial species suggests an important role in bacterial metabolism. To definitively determine its native function, researchers would need to conduct genetic knockout studies combined with metabolomic analyses to identify accumulated substrates or diminished products in YdeN-deficient strains .

How can B. subtilis be utilized as an expression platform for YdeN and similar proteins?

B. subtilis offers several advantages as an expression platform for YdeN and similar proteins:

  • Homologous expression: As YdeN is native to B. subtilis, expressing it in its original host may improve proper folding and activity.

  • Secretion capability: B. subtilis naturally secretes many proteins, potentially allowing for extracellular production of YdeN that simplifies purification.

  • Low endotoxin content: Being a Gram-positive bacterium, B. subtilis contains minimal endotoxin levels compared to E. coli, simplifying downstream purification for certain applications.

  • Spore formation: Engineered B. subtilis strains can form spores, providing a stable long-term storage format for the expression system that can be reactivated when needed .

To optimize expression, researchers should consider:

  • Using an IPTG-inducible promoter system like the groE-lac hybrid promoter

  • Incorporating appropriate secretion signal sequences (e.g., amyQ) if extracellular production is desired

  • Optimizing ribosome binding sites and codon usage for improved translation efficiency

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.